Product category:
Clinical chemistry analysis
News Release from: Sysmex UK | Subject: Roteg
Edited by the Laboratorytalk Editorial
Team on 05 July 2002
Thromboelastography evolves in turn
Rotation thromboelastography provides information on the causes of blood loss in critical situations at the point of care, to allow discrimination between surgical bleeding and true haemostasis
Sysmex UK is the newly appointed exclusive UK distributor of the Roteg rotation thromboelastography system for the rapid differential analysis of blood coagulation (haemostasis) disorders, and has created a dedicated team of specialists offering comprehensive after sales support Rotation thromboelastography has evolved from traditional Thromboelastography to provide the user with advanced differential, diagnostic information
This article was originally published on Laboratorytalk on 26 Mar 2002 at 8.00am (UK)
Related stories
Anatomical pathology system streamlines workflow
Workflow management tool intgegrates data electronically and offers advanced features such as voice recognition, coded text reporting, and full text searching
The next generation LIS
Laboratory information system promises total organisation of laboratory structures, from networks with centralised administration and management down to single laboratories
Thromboelastography (Teg) provides prompt reliable information to clinicians on the causes of blood loss in critical situations at the point of care, and is vital to allow discrimination between surgical bleeding and a true haemostasis disorder.
Commonly located in theatre side room laboratories and intensive care units, Roteg can immediately assist surgeons and anaesthetists when choosing appropriate therapies and reduce the need for non-specific prophylactic transfusions or assist them in making evidence based decisions for the management of acute haemostasis disorders.
In clinical disciplines such as transplantation, haematology, neurosurgery and cardiology, as well as pharmaceutical R and D laboratories, classical clotting assays have limited analytical power, focus on plasma testing and may present problems in terms of turnaround time of results.
Roteg can additionally determine clot characteristics including current stability and the likelihood of lysis, and provides a reliable alternative to laboratory tests or activated clotting time.
This enhanced information is critical in reducing unnecessary blood product use and cost together with improving levels of safety and quality care.
The compact Roteg unit is robust and easily transportable and is operated via a laptop computer equipped with user-friendly software.
Using whole blood samples, a series of differential diagnostic assays are performed using an electronic pipette, which eliminates handling errors and ensures standardised mixing.
The Roteg, which is already established in several European countries, will complement the PFA-100 platelet function analyser (also available from Sysmex UK) which is proven as a useful tool in assessing platelet function and aiding clinical management in a critical care environment.
• Sysmex UK: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
